Centessa Pharmaceuticals plc ADR (NASDAQ:CNTA) price on Thursday, April 10, fall -4.17% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $11.27.
A look at the stock’s price movement, the close in the last trading session was $11.76, moving within a range at $10.45 and $11.78. The beta value (5-Year monthly) was 1.536. Turning to its 52-week performance, $19.09 and $7.75 were the 52-week high and 52-week low respectively. Overall, CNTA moved -33.94% over the past month.
Centessa Pharmaceuticals plc ADR’s market cap currently stands at around $1.49 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-23.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CNTA is a 100% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
6 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 3 analyst(s) rate the stock as a Hold, 3 recommend CNTA as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CNTA’s current price about -21.41% and -28.38% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 31.73, while 7-day volatility ratio is 16.65% and 9.68% in the 30-day chart. Further, Centessa Pharmaceuticals plc ADR (CNTA) has a beta value of 1.58, and an average true range (ATR) of 1.34. Analysts have given the company’s stock an average 52-week price target of $27.5, forecast between a low of $27 and high of $28. Looking at the price targets, the low is -139.57% off current price level while to achieve the yearly target high, price needs to move -148.45%. Nonetheless, investors will most likely welcome a -144.01% jump to $27.5 which is the analysts’ median price.
If we refocus on Centessa Pharmaceuticals plc ADR (NASDAQ:CNTA), historical trading data shows that trading volumes averaged 1.37 over the past 10 days and 990.59K over the past 3 months. The company’s latest data on shares outstanding shows there are 132.63 million shares.
The 36.45% of Centessa Pharmaceuticals plc ADR’s shares are in the hands of company insiders while institutional holders own 54.85% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 4.86 million on 2025-03-14, giving us a short ratio of 4.53. The data shows that as of 2025-03-14 short interest in Centessa Pharmaceuticals plc ADR (CNTA) stood at 432.0 of shares outstanding, with shares short rising to 4.15 million registered in 2025-02-14. Current price change has pushed the stock -32.72% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CNTA stock continues to rise going into the next quarter.
